Prenatal antimicrobial use and early-childhood body mass index

A E Cassidy-Bushrow1,2, C Burmeister1, S Havstad1,2

  • 1Department of Public Health Sciences, Henry Ford Hospital, Detroit, MI, USA.

Insights

Prenatal antibiotic exposure is linked to higher childhood body mass index (BMI) by age two, especially when used in early pregnancy. This finding highlights a potential factor in early childhood obesity risk.

Area of Science:

  • Pediatric Health
  • Maternal Health
  • Microbiome Research

Background:

  • Childhood obesity is a growing concern with potential links to early life exposures.
  • Gut microbiome alterations are implicated in the relationship between antibiotic use and body mass index (BMI).
  • The impact of prenatal antimicrobial exposure on offspring obesity risk remains less understood.

Purpose of the Study:

  • To investigate the association between prenatal antibiotic or antifungal use and offspring BMI at age two.
  • To explore if the timing of prenatal antimicrobial exposure influences childhood BMI.

Main Methods:

  • A birth cohort of 527 participants was analyzed.
  • Prenatal antimicrobial use was recorded from medical records.
  • Child height and weight were measured at age two to calculate BMI, with overweight/obesity defined as BMI at or above the 85th percentile.

Main Results:

  • Prenatal antibiotic use was associated with a higher mean BMI Z-score (0.20±0.10, P=0.046) at age two.
  • No significant association was found between prenatal antifungal use and child BMI.
  • Exposure to antibiotics in the first or second trimester showed a stronger association with increased BMI Z-score and overweight/obesity risk.

Conclusions:

  • Prenatal antibiotic use, particularly in earlier trimesters, is associated with increased childhood BMI at age two.
  • Antifungal use during pregnancy was not linked to offspring BMI.
  • Further research into microbiome alterations is needed; prenatal antibiotic exposure may be a modifiable risk factor for childhood obesity.
Abstract

Related Concept Videos

Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
1.0K
Anatomy of the Intestines01:23

Anatomy of the Intestines

Although digestion of proteins, carbohydrates, and lipids may begin in the stomach, it is completed in the intestine. The absorption of nutrients, water, and electrolytes from food and drink also occurs in the intestine. The intestines can be divided into two structurally distinct organs—the small and large intestines.
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
88.3K
Environmental Influences on Intelligence01:29

Environmental Influences on Intelligence

Despite the strong genetic influence on traits like intelligence, environmental factors significantly shape outcomes. For example, while over 90% of height variation is due to genetic differences, environmental factors such as nutrition also have a notable impact. Similarly, for intelligence, changes in a child's surroundings can significantly alter their IQ. Research shows that enriched environments boost children's academic success and help them develop key cognitive skills. Children...
1.0K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
371
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
356
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.4K